Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells
- PMID: 2846881
- PMCID: PMC253586
- DOI: 10.1128/JVI.62.12.4712-4721.1988
Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells
Abstract
Early-passage rat adrenocortical cells were infected with Kirsten murine sarcoma virus and MMCV mouse myc virus, two retroviruses carrying the v-Ki-ras and v-myc oncogenes, respectively. Efficient morphological transformation required coinfection with the two viruses, was dependent on the presence of high serum concentrations, and was not immediately accompanied by growth in soft agar. The doubly infected cells coordinately acquired the capacity for anchorage- and serum-independent growth during passage in culture. The appearance of such highly transformed cells was correlated with the emergence of a dominant clone, as suggested by an analysis of retrovirus integration sites. These results indicate that the concerted expression of v-Ki-ras and v-myc could induce rapid morphological transformation of nonestablished adrenocortical cells but that an additional genetic or epigenetic event was required to permit full transformation by these two oncogenes. In contrast, v-src, introduced by retrovirus infection in conjunction with v-myc, rapidly induced serum- and anchorage-independent growth. Therefore, the p60v-src protein-tyrosine kinase, unlike p21v-ras, is apparently not restricted in the induction of a highly transformed phenotype in adrenocortical cells. This system provides an in vitro model for the progressive transformation of epithelial cells by dominantly acting oncogenes.
Similar articles
-
Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.Oncogene Res. 1988 Sep;3(2):105-15. Oncogene Res. 1988. PMID: 2465525
-
Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.Oncogene. 1991 Dec;6(12):2311-7. Oncogene. 1991. PMID: 1662792
-
A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.J Virol. 1989 Jan;63(1):338-48. doi: 10.1128/JVI.63.1.338-348.1989. J Virol. 1989. PMID: 2462061 Free PMC article.
-
Differential control of muscle-specific gene expression specified by src and myc oncogenes in myogenic cells.Ciba Found Symp. 1990;150:250-8; discussion 258-61. doi: 10.1002/9780470513927.ch15. Ciba Found Symp. 1990. PMID: 2115425 Review.
-
Retroviral oncogenes: a historical primer.Nat Rev Cancer. 2012 Sep;12(9):639-48. doi: 10.1038/nrc3320. Epub 2012 Aug 17. Nat Rev Cancer. 2012. PMID: 22898541 Free PMC article. Review.
Cited by
-
Stat3 activation is required for cellular transformation by v-src.Mol Cell Biol. 1998 May;18(5):2553-8. doi: 10.1128/MCB.18.5.2553. Mol Cell Biol. 1998. PMID: 9566875 Free PMC article.
-
Cellular aging is a critical determinant of primary cell resistance to v-src transformation.J Virol. 1997 Jan;71(1):237-47. doi: 10.1128/JVI.71.1.237-247.1997. J Virol. 1997. PMID: 8985343 Free PMC article.
-
Constitutive phosphorylation of a Rac GAP MgcRacGAP is implicated in v-Src-induced transformation of NIH3T3 cells.Cancer Sci. 2009 Sep;100(9):1675-9. doi: 10.1111/j.1349-7006.2009.01235.x. Epub 2009 May 31. Cancer Sci. 2009. PMID: 19555392 Free PMC article.
-
Mammalian neural stem-cell renewal: nature versus nurture.Mol Neurobiol. 2003 Feb;27(1):73-98. doi: 10.1385/MN:27:1:73. Mol Neurobiol. 2003. PMID: 12668902 Review.
-
Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.Jpn J Cancer Res. 1999 Jan;90(1):40-7. doi: 10.1111/j.1349-7006.1999.tb00663.x. Jpn J Cancer Res. 1999. PMID: 10076563 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous